Article

Anticoagulation Therapy for Venous Thromboembolism From Vitamin K Antagonists to Direct Oral Anticoagulants and Beyond

2026-08-12

Abstract excerpt

<title>Abstract</title> <p>Anticoagulation therapy for venous thromboembolism has shifted from vitamin K antagonists to direct oral anticoagulants (DOAC). However, balancing thrombotic and bleeding risks remains a major challenge in the DOAC era. Emerging therapies, such as factor XI inhibitors, may expand treatment options, particularly for selected high-bleeding risk patients. Furthermore, future strategies wil...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0f905604-1d83-5967-a2fc-11364e5c5e3b
DOI: 10.21203/rs.3.rs-10561239/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Anticoagulation Therapy for Venous Thromboembolism From Vitamin K Antagonists to Direct Oral Anticoagulants and BeyondDOI 10.21203/rs.3.rs-10561239/v1Read

Management of inherited thrombophilia: guide for genetics professionals.Semantic proximity Read

A novel rationale for targeting FXI: Insights from the hemostatic miRNA targetome for emerging anticoagulant strategiesSemantic proximity Read

Advances in understanding pathogenic mechanisms of thrombophilic disorders.Semantic proximity Read

Direct oral anticoagulants in patients with severe inherited thrombophilia: a single-center cohort study.Semantic proximity Read

Direct Oral Anticoagulants in Patients with Thrombophilia: Challenges in Diagnostic Evaluation and Treatment.Semantic proximity Read

Prediction of Venous Thromboembolism Based on Clinical and Genetic FactorsSemantic proximity Read

Evolving paradigm in thrombophilia screeningSemantic proximity Read

Inherited Thrombophilia: Implications for Prevention and Treatment of Venous ThromboembolismSemantic proximity Read

[Advances in the genetics of venous thromboembolic disease].Semantic proximity Read

Thrombophilia, risk factors and preventionSemantic proximity Read

Genetic assessment of efficacy and safety profiles of coagulation cascade proteins identifies Factors II and XI as actionable anticoagulant targetsSemantic proximity Read

Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence.Semantic proximity Read